Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

RESCEU

Financiado

Cerrado

REspiratory Syncytial virus Consortium in EUrope Sofia ref. 116019

RSV causes severe disease and results in substantial healthcare costs in individuals at the extremes of the age spectrum and in high risk groups. RESCEU brings together academia, national public health agencies and EFPIA with prov... ver más

30/09/2022

UEDIN

25M€

Presupuesto del proyecto: 25M€

Líder del proyecto

THE UNIVERSITY OF EDINBURGH No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Fecha límite participación Sin fecha límite de participación.

Ver 21 Participantes

Financiación concedida El organismo H2020 notifico la concesión del proyecto el día 2022-09-30

IMI2-2015-06-02: Establishing impact of RSV infectio...

I+D

Cerrada hace 9 años

0% 57% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

21 Participantes

UEDIN

3.60M€ | Lider

IBERIA LAE

1.07M€ | Participante

SYNAPSE

613.27K€ | Participante

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Proyectos interesantes

REACT Respiratory Host-Pathogen Interaction 8M€ Cerrado

PARIS Proteomics-based Analysis of RSV nucleic acid/protein Intera... 190K€ Cerrado

PHA-ST-TRAIN-VAC Leveraging Pharmaceutical Sciences and Structural Biology Tr... 1M€ Cerrado

PROMISE Preparing for RSV Immunisation and Surveillance in Europe 7M€ Cerrado

CLARITY Causative Link between respirAtory syncytial viRus and chron... 7M€ Cerrado

BIO2016-75549-R BASES MOLECULARES DE LA VIRULENCIA DE CORONAVIRUS RESPIRATOR... 290K€ Cerrado

Duración del proyecto: 69 meses Fecha Inicio: 2016-12-14
Fecha Fin: 2022-09-30

Líder del proyecto

THE UNIVERSITY OF EDINBURGH No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 25M€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto RSV causes severe disease and results in substantial healthcare costs in individuals at the extremes of the age spectrum and in high risk groups. RESCEU brings together academia, national public health agencies and EFPIA with proven expertise and a strong track record in RSV research. The academic partners are leaders in RSV epidemiology, clinical RSV research, health economics, and vaccinology; and key opinion leaders with advisory roles in European and national public health bodies, health technology agencies and vaccine advisory groups. EFPIA participants (AZ, GSK, JPNV, Novavax, Pfizer, and SP) have active clinical research programmes to develop lead candidates for treatment and prevention of RSV in infants, adults and the elderly. As part of RESCEU, EFPIA participants will contribute expertise in a wide range of fields including infectious disease, clinical medicine, immunology, epidemiology, biostatistics, biomarker development, global health, and health economics. RESCEU’s aim is to develop robust evidence on RSV disease burden and economic impact; create a sustainable Europe-wide multidisciplinary, multi-stakeholder community from academia, public health, scientific societies, patient organisations, regulatory agencies and industry; and provide infrastructure to perform future pivotal trials for RSV vaccines and therapeutics. RESCEU aims to provide sustainable longer term impact on RSV disease burden and thus make a significant contribution to improved health and wellbeing in Europe. The project will comprise 6 work packages. WP 1-3 will identify and marshal data from large-scale systematic reviews of epidemiological and cost studies, disease registries, linked routine (national) healthcare and claims datasets and will establish a framework for and assemble data from RSV surveillance in Europe to estimate RSV disease burden on health services and inform economic models.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores